ADM ADM Special Populations & Cultural Considerations 1 — Questions and Answers
Question 1: Which organization provides the primary clinical guidelines for managing opioid use disorder during pregnancy in the United States?
- DEA
- ACOG (American College of Obstetricians and Gynecologists) (Correct answer)
- ADA
- The Joint Commission
Correct answer: ACOG (American College of Obstetricians and Gynecologists)
ACOG provides evidence-based guidelines for managing opioid use disorder during pregnancy, recommending medication-assisted treatment with methadone or buprenorphine.
Question 2: What is the recommended first-line pharmacotherapy for opioid use disorder in pregnant women?
- Naltrexone extended-release injection
- Methadone or buprenorphine-based MAT (Correct answer)
- Naloxone alone
- Clonidine for detoxification
Correct answer: Methadone or buprenorphine-based MAT
Methadone or buprenorphine-based medication-assisted treatment is the recommended first-line approach for OUD in pregnancy, as opioid withdrawal can cause fetal distress.
Question 3: Current evidence-based management of Neonatal Opioid Withdrawal Syndrome (NOWS) recommends which initial approach?
- Immediate ICU transfer without parental involvement
- Non-pharmacological comfort measures first, with pharmacotherapy added if needed (Correct answer)
- Immediate morphine infusion for all affected newborns
- Rapid naloxone administration to reverse withdrawal
Correct answer: Non-pharmacological comfort measures first, with pharmacotherapy added if needed
Current NOWS guidelines support starting with non-pharmacological comfort measures (rooming-in, breastfeeding, reduced stimulation) before escalating to pharmacotherapy.
Question 4: What most differentiates adolescent patients with SUD from adult patients when considering treatment approaches?
- Adolescents experience fewer withdrawal symptoms
- The adolescent brain is still developing, increasing vulnerability to addiction (Correct answer)
- Adolescents respond better to all pharmacotherapies
- Social factors are less influential in adolescent SUD
Correct answer: The adolescent brain is still developing, increasing vulnerability to addiction
The adolescent brain, particularly the prefrontal cortex, is still developing, making youth more vulnerable to addiction and the long-term consequences of substance use.
Question 5: Which treatment approach does SAMHSA specifically recommend for adolescents with substance use disorders?
- Mixed adult/adolescent therapeutic communities
- Family-based therapy models such as MDFT or Functional Family Therapy (Correct answer)
- Methadone maintenance identical to adult protocols
- 28-day residential programs using adult protocols
Correct answer: Family-based therapy models such as MDFT or Functional Family Therapy
Family-based therapy models are specifically recommended for adolescents with SUD because family involvement is a critical factor in adolescent recovery.
Question 6: When treating elderly patients with substance use disorders, which pharmacokinetic factor most requires clinical attention?
- Elderly patients rarely develop tolerance to medications
- Age-related changes in hepatic metabolism and renal function affect drug dosing (Correct answer)
- Standard adult dosing protocols apply unchanged in the elderly
- Substance use disorders are always secondary to pain in the elderly
Correct answer: Age-related changes in hepatic metabolism and renal function affect drug dosing
Elderly patients experience age-related reductions in hepatic metabolism and renal function that cause drugs to remain active longer, requiring careful dose adjustments.
ADM ADM Special Populations & Cultural Considerations 1
Which organization provides the primary clinical guidelines for managing opioid use disorder during pregnancy in the United States?